CompletedPHASE1, PHASE2NCT00411996

The Pharmacokinetics and Safety of IDV/r With NRTIs in HIV/TB Co-infected Patients Receiving Rifampicin

Studying Tuberculosis

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
The HIV Netherlands Australia Thailand Research Collaboration
Principal Investigator
Kiat Ruxrungtham, MD
HIV-NAT, Thai Red Cross AIDS Research Center
Intervention
indinavir/ritonavir(drug)
Enrollment
20 enrolled
Eligibility
18-60 years · All sexes
Timeline
2006 – 2009

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00411996 on ClinicalTrials.gov

Other trials for Tuberculosis

Additional recruiting or active studies for the same condition.

See all trials for Tuberculosis →

← Back to all trials